Adherence to clinical guidelines for Barrett’s esophagus

References

• Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet 2017;22:31462–31469.
   Google Scholar
• Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371:836–845.
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7–42.
   PubMed Web of Science ®Google Scholar
• Codipilly DC, Chandar AK, Singh S, et al. The effect of endoscopic surveillance in patients with Barrett’s esophagus: a systematic review and meta-analysis. Gastroenterology. 2018;154:2068–2086.
   PubMed Web of Science ®Google Scholar
• Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–1383.
   PubMed Web of Science ®Google Scholar
• Holmberg D, Ness-Jensen E, Mattsson F, et al. Risk of oesophageal adenocarcinoma in individuals with Barrett’s oesophagus. Eur J Cancer. 2017;75:41–46.
   PubMed Web of Science ®Google Scholar
• Holmberg D, Ness-Jensen E, Mattsson F, et al. Clinical prediction model for tumor progression in Barrett's esophagus. Surg Endosc. 2018;1–8. https://doi.org/10.1007/s00464-018-6590-5
   Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:1–16.
   PubMed Web of Science ®Google Scholar
• Lindblad M, Ye WM, Lindgren AS, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243:479–485.
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Vall A, Mattsson F, et al. Tumour staging of oesophageal cancer in the Swedish cancer registry: a nationwide validation study. Acta Oncol. 2015;54:903–908.
   PubMed Web of Science ®Google Scholar
• Brooke H, Talbäck M, Hörnblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32:765–773.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16:726–735.
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Lagergren J. The Charlson comorbidity index in registry-based research. Methods Inf Med. 2017;56:401–406.
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 2002;97:1888–1895.
   PubMed Web of Science ®Google Scholar
• Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570.
   PubMed Web of Science ®Google Scholar
• Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s Esophagus. Am J Gastroenterol. 2008;103:788–797.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, et al. American gastroenterological association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:e18–1091.
   PubMed Web of Science ®Google Scholar
• Evans JA, Early DS, Fukami N, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76:1087–1094.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Duan Z, Hinojosa-Lindsey M, et al. Practice patterns of surveillance endoscopy in a veterans affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc. 2012;76:743–755.
   PubMed Web of Science ®Google Scholar
• Tavakkoli A, Appelman HD, Beer DG, et al. Use of appropriate surveillance for patients with non-dysplastic Barrett’s esophagus. Clin Gastroenterol Hepatol. 2018;16:862–869.
   PubMed Web of Science ®Google Scholar
• Faqih A, Broman KK, Huang LC, et al. Frequency of endoscopic surveillance for Barrett’s esophagus is influenced by health insurance status: results from a population-based analysis. Dis Esophagus. 2017;30:1.
   PubMed Web of Science ®Google Scholar
• Vogt JS, Larsen AC, Sommer T, et al. Quality of endoscopic surveillance of Barrett’s esophagus. Scand J Gastroenterol. 2018;53:256–259.
   PubMed Web of Science ®Google Scholar
• Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.
   PubMed Web of Science ®Google Scholar
• Levine DS, Blount PL, Rudolph RE, et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95:1152–1157.
   PubMed Web of Science ®Google Scholar
• Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67:394–398.
   PubMed Web of Science ®Google Scholar
• Singh S, Manickam P, Amin AV, et al. Incidence of esophageal adenocarcinoma in Barrett’s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79:897–909.
   PubMed Web of Science ®Google Scholar
• Amamra N, Touzet S, Colin C, et al. Current practice compared with the international guidelines: endoscopic surveillance of Barrett’s esophagus. J Eval Clin Pract. 2007;13:789–794.
   PubMed Web of Science ®Google Scholar
• Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett’s oesophagus in the UK. Aliment Pharmacol Ther. 2003;17:1319–1324.
   PubMed Web of Science ®Google Scholar
• di Pietro M, Fitzgerald RC. Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia. Gut. 2018;2:392–393.
   Web of Science ®Google Scholar
• El-Serag HB, Naik AD, Duan ZG, et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut. 2016;65:1252–1260.
   PubMed Web of Science ®Google Scholar
• Tramontano AC, Sheehan DF, Yeh JM, et al. The impact of a prior diagnosis of Barrett’s esophagus on esophageal adenocarcinoma survival. Am J Gastroenterol. 2017;4:82.
   Google Scholar
• Fudman DI, Lightdale CJ, Poneros JM, et al. Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus. Gastrointest Endosc. 2014;80:71–77.
   PubMed Web of Science ®Google Scholar
• Pasricha S, Cotton C, Hathorn KE, et al. Effects of the learning curve on efficacy of radiofrequency ablation for Barrett’s esophagus. Gastroenterology. 2015;149:890–896.
   PubMed Web of Science ®Google Scholar